The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
Why today’s AI systems struggle with consistency, and how emerging world models aim to give machines a steady grasp of space ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback